Home - Products - Metabolic Enzyme/Protease - DPP - WAY 316606

WAY 316606

CAS No. 915759-45-4

WAY 316606( —— )

Catalog No. M19258 CAS No. 915759-45-4

WAY 316606 is an inhibitor of the secreted protein sFRP-1, an endogenous antagonist of the secreted glycoprotein Wnt.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	46	In Stock
5MG	41	In Stock
10MG	67	In Stock
25MG	122	In Stock
50MG	200	In Stock
100MG	323	In Stock
200MG	462	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

WAY 316606
Note

Research use only, not for human use.
Brief Description

WAY 316606 is an inhibitor of the secreted protein sFRP-1, an endogenous antagonist of the secreted glycoprotein Wnt.
Description

WAY 316606 is an inhibitor of the secreted protein sFRP-1, an endogenous antagonist of the secreted glycoprotein Wnt.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Metabolic Enzyme/Protease
Target

DPP
Recptor

sFRP-1
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

915759-45-4
Formula Weight

448.48
Molecular Formula

C18H19F3N2O4S2
Purity

>98% (HPLC)
Solubility

DMSO : ≥ 100 mg/mL; 222.98 mM
SMILES

FC(F)(F)c1ccc(cc1S(=O)(=O)NC1CCNCC1)S(=O)(=O)c1ccccc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Moore, WJ, et al.Journal of Medicinal Chemistry (2009), 52(1), 105-116.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

P32/98 hemifumarate

P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the Zucker diabetic rat model, and may be useful in studies of type 2 diabetes and colitis.
Denagliptin

Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine ü metabolic diseases and can be used in the study of type 2 diabetes.
Trelagliptin

Trelagliptin is a highly selective, long-acting DPP-4 inhibitor. Phase 3.

Sign In Join Free